Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India. Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India. Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India. Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India. Collaboration marks a significant milestone in improving emergency healthcare services in the country
BI India joins forces with PPAM and BMC to Stop Rabies BI India joins forces with PPAM and BMC to Stop Rabies This initiative will adopt a two-pronged approach of vaccination and education.
Boehringer Ingelheim India recognized as Top Employer 2024 Boehringer Ingelheim India recognized as Top Employer 2024 Boehringer Ingelheim India recognized as Top Employer 2024
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease Jardiance® (empagliflozin) now approved in India
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults CDSCO approves SPEVIGO® (spesolimab)
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
COVID-19 Boehringer Ingelheim Singapore JSS donations COVID-19 Boehringer Ingelheim Singapore JSS donations Boehringer Ingelheim Singapore donates government payouts for more good causes, giving back to patients and animals who need it the most. Learn more.
COVID-19 Boehringer Ingelheim Singapore charity donations COVID-19 Boehringer Ingelheim Singapore charity donations Find out how Boehringer Ingelheim Singapore is offering support for healthcare workers and vulnerable communities. Click here to learn more.